SYRE · Company research
Spyre Therapeutics, Inc. Common Stock (SYRE): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 80.11 | $7,208,898,082.8 | 7046891082.80 | 1.6716738197424893 | — | — | — | 6.5467529433560280 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.